Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
ACS Omega|January 15, 2024
In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite NanoparticlesBanafsheh Rastegari, Atefe Ghamar Talepoor, Shahdad Khosropanah, et al.
Colloids and Surfaces. B, Biointerfaces|July 28, 2017
The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studiesBanafsheh Rastegari, Hamid Reza Karbalaei-Heidari, Sedigheh Zeinali, et al.
Preparative Biochemistry & Biotechnology|December 6, 2021
Immobilization of horseradish peroxidase on lysine-functionalized gum Arabic-coated Fe3O4 nanoparticles for cholesterol determinationMorteza Varamini, Hajar Zamani, Hale Hamedani, et al.
Lasers in Medical Science|September 26, 2022
The effectiveness of antimicrobial photodynamic therapy with prodigiosin against reference strains of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosaAmin Derakhshanfar, Banafsheh Rastegari, Hossein Sharifi, et al.
ACS Omega|March 31, 2025
P53 Gene Therapy with ZIF-8 Metal-Organic Framework: A Platform in Cancer Gene TherapyRoya Salari, Banafsheh Rastegari, Amin Hashemi, et al.
Histochemistry and Cell Biology|July 30, 2026
Development of a 3D collagen type I hydrogel scaffold for modeling hyperglycemia-induced spinal neuronal damage and therapeutic evaluationMohammad Ranjbar, Kianoosh Ghiasvand, Banafsheh Rastegari, et al.
Bioorganic & Medicinal Chemistry|March 1, 2016
Interaction of prodigiosin with HSA and β-Lg: Spectroscopic and molecular docking studiesBanafsheh Rastegari, Hamid Reza Karbalaei-Heidari, Reza Yousefi, et al.
Dalton Transactions (Cambridge, England : 2003)|March 11, 2016
Synthesis, characterization, DNA binding, cleavage activity, cytotoxicity and molecular docking of new nano water-soluble [M(5-CH₂PPh₃-3,4-salpyr)](ClO₄)₂ (M = Ni, Zn) complexesZeinab Mandegani, Zahra Asadi, Mozaffar Asadi, et al.
Therapeutic Delivery|May 25, 2026
Target-specific daunorubicin nanoplatform based on anti-CD22-ScFv decorated β-cyclodextrin metal organic frameworksAlireza Khabiri, Banafsheh Rastegari, Gholamreza Rafiei Dehbidi, et al.
Current Pharmaceutical Biotechnology|April 15, 2024
SiRNA-mediated Knockdown of ABCB1 Enhances the Efficacy of Doxorubicin and Vinorelbine in Breast Cancer CellsZahra Abbasfard, Abbas Behzad-Behbahani, Banafsheh Rastegari, et al.
Pageof 3